Continuous subcutaneous insulin infusion in patients with type 2 diabetes safely improved glycaemic control using a simple insulin dosing regimen

被引：0

作者：

Edelman, S. V. ^{[1
]}

Bode, B. W. ^{[2
]}

Bailey, T. S.

Kipnes, M. S. ^{[3
]}

Chen, X. ^{[4
]}

Frias, J. P. ^{[5
]}

机构：

[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA

[2] Atlanta Diabet Assoc, Atlanta, GA USA

[3] Cetero Res, San Antonio, TX USA

[4] LifeScan Inc, Milpitas, CA USA

[5] LifeScan Inc, Clin Affairs, W Chester, PA USA

来源：

DIABETOLOGIA | 2009年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

943

引用

页码：S370 / S371

页数：2

共 50 条

[41] Sustained glycaemic improvement with continuous subcutaneous insulin infusion (CSII) therapy in a patient with insulin-resistant Type 2 diabetes: A case report
Balafshan, T.
Furlong, N.
[J]. DIABETIC MEDICINE, 2018, 35 : 15 - 15
[42] World travel with type 1 diabetes using continuous subcutaneous insulin infusion
Charlton, Alexander R.
Charlton, Jessica R.
[J]. BRITISH JOURNAL OF DIABETES, 2019, 19 (02): : 141 - 146
[43] Improved Glycemic Control in Pregnancy Using Continuous Subcutaneous Infusion of Concentrated Insulin
Mon, Nandar
Krishnasamy, Sathya
[J]. DIABETES, 2023, 72
[44] Continuous subcutaneous insulin infusion in diabetes: when Type 2 diabetes is not a NICE label
Paxton, C. A.
Rainford, A.
Ooi, C. G.
[J]. DIABETIC MEDICINE, 2008, 25
[45] Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion
Dicembrini, Ilaria
Mannucci, Edoardo
Monami, Matteo
Pala, Laura
[J]. DIABETES OBESITY & METABOLISM, 2019, 21 (12): : 2619 - 2625
[46] Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion
Pickup, J. C.
Sutton, A. J.
[J]. DIABETIC MEDICINE, 2008, 25 (07) : 765 - 774
[47] Comparison of the Efficiency of Different Rapid-Acting Insulin Analogues used in Continuous Subcutaneous Insulin Infusion in the Glycaemic Control of Children with Type 1 Diabetes
Mota, Silvia
Pereira, Beatriz Belo
Carvalho, Vasco
Gomes, Maria Miguel
Nascimento, Patricia
Correia, Filipa
Dias, Angela
Martins, Sofia
[J]. REVISTA PORTUGUESA DE ENDOCRINOLOGIA DIABETES E METABOLISMO, 2021, 16 (3-4) : 88 - 93
[48] Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion
Siebenhofer, A.
Jeitler, K.
Berghold, A.
Horvath, K.
Pieber, T. R.
[J]. DIABETIC MEDICINE, 2009, 26 (03) : 312 - 312
[49] Continuous subcutaneous insulin infusion for treatment of type 2 diabetes mellitus.
Davidson, PC
Jeng, L
Ghegan, M
Winsett, J
Bode, BW
[J]. DIABETOLOGIA, 1999, 42 : A212 - A212
[50] Comparison of continuous subcutaneous insulin infusion (CSII) with flexible multiple daily insulin (FMDI) regimen using insulin glargine in pediatric type 1 diabetes Mellitus
Alemzadeh, R
Ellis, J
Holzum, M
Parton, E
[J]. DIABETES, 2003, 52 : A101 - A101

← 1 2 3 4 5 →